We hereby submit the Un-Audited Financial Results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Multibase India reported a weak Q1 FY26 with revenue from operations falling to Rs 1,675.71 lakhs, down about 12.8% from Rs 1,922.87 lakhs in the same quarter last year. Total income also slipped from Rs 2,116.26 lakhs to Rs 1,762.47 lakhs. Net profit after tax nearly halved to Rs 229.65 lakhs versus Rs 392.27 lakhs in Q1 FY25, a drop of roughly 41%, while EPS fell to Rs 1.82 from Rs 3.11. Compared to the previous quarter (Q4 FY25), revenue was nearly flat but PAT dropped about 43% from Rs 406.80 lakhs. The statutory auditor MSKA & Associates issued a clean limited review report with no qualifications or emphasis of matter. A related-party note disclosed a Rs 231.62 lakhs credit note received from its French holding company Multibase S.A for a transfer pricing adjustment.
Sharply lower profits despite stable revenues signal margin pressure and weaker demand for the company's thermoplastic compounds business. Shareholders should note the steep YoY earnings decline, though the company remains profitable and the audit review was clean.